Trial Profile
A 6-Week Double-Blind, Parallel-Group, Active-Controlled Trial to Compare the Efficacy and Safety of Concomitant Treatment of Formoterol Fumarate Inhalation Solution 20 Mcg Twice Daily and Tiotropium 18 Mcg Once Daily to Tiotropium 18 Mcg Once Daily Alone in the Treatment of Patients With Chronic Obstructive Pulmonary Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 May 2009
Price :
$35
*
At a glance
- Drugs Formoterol (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 19 May 2009 Results of a pooled analysis of two similar studies (700025582 and 700016929) presented at the ATS conference in May 2009, according to a Dey LP media release.
- 20 May 2008 Results were presented at the International ATS Conference 2008.
- 01 Apr 2008 Primary endpoint results have been published